| GO ID |
Ontology |
Definition |
Evidence |
Reference |
| GO:0002931 |
Process |
Response to ischemia |
ISS |
30497184 |
| GO:0003245 |
Process |
Cardiac muscle tissue growth involved in heart morphogenesis |
ISS |
|
| GO:0003300 |
Process |
Cardiac muscle hypertrophy |
ISS |
|
| GO:0003730 |
Function |
MRNA 3'-UTR binding |
IDA |
25240198, 26440600 |
| GO:0008285 |
Process |
Negative regulation of cell population proliferation |
IDA |
24294368 |
| GO:0010666 |
Process |
Positive regulation of cardiac muscle cell apoptotic process |
ISS |
|
| GO:0010715 |
Process |
Regulation of extracellular matrix disassembly |
ISS |
25201911 |
| GO:0010972 |
Process |
Negative regulation of G2/M transition of mitotic cell cycle |
ISS |
|
| GO:0016442 |
Component |
RISC complex |
IEA |
|
| GO:0030514 |
Process |
Negative regulation of BMP signaling pathway |
IDA |
31921616 |
| GO:0032691 |
Process |
Negative regulation of interleukin-1 beta production |
ISS |
30497184 |
| GO:0032715 |
Process |
Negative regulation of interleukin-6 production |
ISS |
30497184 |
| GO:0032720 |
Process |
Negative regulation of tumor necrosis factor production |
ISS |
30497184 |
| GO:0035195 |
Process |
MiRNA-mediated post-transcriptional gene silencing |
HDA |
18320040 |
| GO:0035195 |
Process |
MiRNA-mediated post-transcriptional gene silencing |
IDA |
23487264, 24294368, 25240198, 26440600, 26823724, 29665645, 30497184 |
| GO:0035195 |
Process |
MiRNA-mediated post-transcriptional gene silencing |
IEA |
|
| GO:0035279 |
Process |
MiRNA-mediated gene silencing by mRNA destabilization |
IDA |
31921616 |
| GO:0043065 |
Process |
Positive regulation of apoptotic process |
IDA |
24294368 |
| GO:0043124 |
Process |
Negative regulation of canonical NF-kappaB signal transduction |
IDA |
23487264 |
| GO:0045719 |
Process |
Negative regulation of glycogen biosynthetic process |
IMP |
25240198 |
| GO:0045930 |
Process |
Negative regulation of mitotic cell cycle |
ISS |
|
| GO:0046627 |
Process |
Negative regulation of insulin receptor signaling pathway |
IMP |
25240198 |
| GO:0060392 |
Process |
Negative regulation of SMAD protein signal transduction |
IDA |
31921616 |
| GO:0061049 |
Process |
Cell growth involved in cardiac muscle cell development |
ISS |
|
| GO:0090272 |
Process |
Negative regulation of fibroblast growth factor production |
IMP |
26823724 |
| GO:0106222 |
Function |
LncRNA binding |
IDA |
31921616 |
| GO:0150079 |
Process |
Negative regulation of neuroinflammatory response |
ISS |
30497184 |
| GO:1900077 |
Process |
Negative regulation of cellular response to insulin stimulus |
IMP |
25240198 |
| GO:1903231 |
Function |
MRNA base-pairing post-transcriptional repressor activity |
IDA |
24294368, 25240198, 26440600, 26823724, 29665645, 30497184, 31921616 |
| GO:1903377 |
Process |
Negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway |
ISS |
30497184 |
| GO:1904046 |
Process |
Negative regulation of vascular endothelial growth factor production |
HMP |
18320040 |
| GO:1904046 |
Process |
Negative regulation of vascular endothelial growth factor production |
IMP |
26823724 |
| GO:1905205 |
Process |
Positive regulation of connective tissue replacement |
ISS |
|
| GO:2000752 |
Process |
Regulation of glucosylceramide catabolic process |
IGI |
25584808 |